Advertisement

Latest News

Iptacopan Boosts Hemoglobin Levels in Adults with PNH in Phase 3b Trial

32 minutes ago

Topline results from APPULSE-PNH show the positive efficacy and safety of twice-daily oral iptacopan in adults with PNH switched from anti-C5 therapies.

Seladelpar’s Impact on Pruritus

1 hour ago

Andreas Kremer, MD, PhD, MHBA, explains seladelpar’s impact on pruritus in PBC based on findings from a posthoc analysis of the RESPONSE trial.

Emerging Second-Line Therapies in PBC

1 hour ago

Andreas Kremer, MD, PhD, MHBA, reviews emerging therapies in PBC, focusing specifically on seladelpar and its impact on pruritus.

Unmet Needs for Pruritus Management in PBC

1 hour ago

Andreas Kremer, MD, PhD, MHBA, explains shortcomings of traditional PBC therapies for addressing pruritus and what advantages newer agents may offer.

Understanding Pruritus in Primary Biliary Cholangitis

1 hour ago

Andreas Kremer, MD, PhD, MHBA, describes the burden of pruritus in PBC and the toll it can take on patients’ quality of life.

Advertisement
Advertisement